Drug recall · October 13, 2021
Meclizine HCl Tablets recall
Why: Labeling: Incorrect Instructions
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01
- Lots / codes
Lot # CB21024, Exp 2/2023
- Quantity
- 1,344 bottles
- Company
- Rising Pharmaceuticals, East Brunswick, NJ
- Distribution
- to be entered
- Initiated
- September 2, 2021 · Voluntary: Firm initiated
- Classified
- October 7, 2021
- Reported
- October 13, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Meclizine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.